SLC22A13 and cancer: Further studies using the GEPIA database revealed that the expression levels of SLC22A6, SLC22A7, SLC22A13, SLC25A4, SLC34A1, and SLC44A4 in ccRCC correlated with the clinical stage of the cancer, as shown in Figure 3(b).